As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Thursday, Medicines (MDCO)'s Director, Fredric N. Eshelman, made a $20.99M purchase of MDCO, buying 621,720 shares at a cost of $33.77 a piece. Eshelman was up about 6.3% on the buy at the high point of today's trading session, with MDCO trading as high as $35.88 in trading on Friday. Medicines is trading up about 7.6% on the day Friday. Before this latest buy, Eshelman made one other buy in the past year, purchasing $10.10M shares at a cost of $33.68 each.
And on Wednesday, Chief Financial Officer James E. Fickenscher purchased $98,570 worth of Zynerba Pharmaceuticals (NASDAQ:ZYNE), purchasing 7,000 shares at a cost of $14.08 a piece. Zynerba Pharmaceuticals is trading up about 3.7% on the day Friday. So far Fickenscher is in the green, up about 16.7% on their buy based on today's trading high of $16.43.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.